Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia
KONOPLEVA, Marina Y, WALTER, Roland B, HONGBO LU, DEBOSE, Lakiesha, BURGER, Jan A, ANDREEFF, Michael, WENBIN LIU, BAGGERLY, Keith A, KORNBLAU, Steven M, DOYLE, L. Austin, ESTEY, Elihu H, KANTARJIAN, Hagop M, FADERL, Stefan H, JABBOUR, Elias J, ZHIHONG ZENG, BORTHAKUR, Gautam, XUELIN HUANG, KADIA, Tapan M, RUVOLO, Peter P, FELIU, Jennie B
Published in Clinical cancer research (15.04.2014)
Published in Clinical cancer research (15.04.2014)
Get full text
Journal Article
Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myeloid Leukemia
Konopleva, Marina Y., Walter, Roland B., Faderl, Stefan H., Jabbour, Elias J., Zeng, Zhihong, Borthakur, Gautam, Huang, Xuelin, Kadia, Tapan M., Ruvolo, Peter P., Feliu, Jennie B., Lu, Hongbo, Debose, LaKiesha, Burger, Jan A., Andreeff, Michael, Liu, Wenbin, Baggerly, Keith A., Kornblau, Steven M., Doyle, L. Austin, Estey, Elihu H., Kantarjian, Hagop M.
Published in Clinical cancer research (28.02.2014)
Published in Clinical cancer research (28.02.2014)
Get full text
Journal Article